<HTML>
<HEAD>
<TITLE> </TITLE>
</HEAD>
<BODY bgcolor="#ffffff" style='font-family:"Times New Roman"'>





<p style=' margin-bottom:0pt; margin-top:0pt;text-align:right;'><font size=1>Registration No. 333-__________<BR>
As filed with the Securities and Exchange Commission on January 29, 2009</font></p>

<div style="border:none;border-bottom:solid .05em;padding:0in 0in 1.0pt 0in">
<div style="border:none;border-bottom:solid .05em;padding:0in 0in 1.0pt 0in"></div></div>
<BR>


<p style=' margin-bottom:0pt; margin-top:6pt;text-align:center;'><B><font SIZE=2>UNITED STATES</font></B></p>

<p style=' margin-bottom:0pt; margin-top:0pt;text-align:center;'><B><font SIZE=2>SECURITIES AND EXCHANGE COMMISSION</font></B></p>

<p style=' margin-bottom:0pt; margin-top:0pt;text-align:center;'><font size=2>Washington, D.C. 20549</font></p>

<p style=' margin-bottom:6pt; margin-top:0pt;text-align:center;'><b><font size=2>____________________</font></b></p>

<p style=' margin-bottom:0pt; margin-top:0pt;text-align:center;'><B><font SIZE=2>FORM</font></B><font size=2>&nbsp;</font><B><font SIZE=2>S-8</font></B></p>

<p style=' margin-bottom:0pt; margin-top:0pt;text-align:center;'><B><font SIZE=2>REGISTRATION STATEMENT</font></B></p>

<p style=' margin-bottom:0pt; margin-top:0pt;text-align:center;'><b><font size=2>Under</font></b></p>

<p style=' margin-bottom:0pt; margin-top:0pt;text-align:center;'><B><font SIZE=2>THE SECURITIES ACT OF 1933</font></B></p>

<p style=' margin-bottom:6pt; margin-top:0pt;text-align:center;'><font size=2>____________________</font></p>

<p style=' margin-bottom:12pt; margin-top:0pt;text-align:center;'><B><font SIZE=2>BSD MEDICAL CORPORATION</font></B></p>

<p style=' margin-bottom:4pt; margin-top:0pt;text-align:center;'><font size=2>(Exact name of registrant as specified in its charter)</font></p>


<table width="100%" border="0" cellspacing=0 cellpadding=0 style='border-collapse:collapse; '>
    <tr >
        <td width="505" valign=top style='padding:0in 5.4pt 0in 5.4pt;border-color:gray'>
            <p style='margin-left:0pt;text-indent:0pt;text-align:center;margin-top:0pt;margin-bottom:0pt'><u><font size=2>


&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Delaware
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></u><br>
<font   size=2>(State   or   other   jurisdiction</font><br>   <font   size=2>of
incorporation or organization)</font></p> </td>
        <td width="50%" valign=top style='padding:0in 5.4pt 0in 5.4pt'>
            <p style='margin-left:0pt;text-indent:0pt;text-align:center;margin-top:0pt;margin-bottom:0pt'><u><font size=2>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;75-1590407&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></u><br> <font size=2>(I.R.S. Employer</font><br> <font size=2>Identification No.)</font></p> </td> </tr></table>

<p style=' margin-bottom:0pt; margin-top:2pt;text-align:center;'><font size=2>2188 West 2200 South</font></p>

<p style=' margin-bottom:4pt; margin-top:0pt;text-align:center;'><font size=2>Salt Lake City, Utah  84119</font></p>

<p style=' margin-bottom:0pt; margin-top:0pt;text-align:center;'><font size=2>(Address, including zip code,</font></p>

<p style=' margin-bottom:0pt; margin-top:0pt;text-align:center;'><font size=2>of registrant&#146;s principal executive offices)</font></p>

<p style=' margin-bottom:4pt; margin-top:0pt;text-align:center;'><font size=2>____________________</font></p>

<p style=' margin-bottom:0pt; margin-top:0pt;text-align:center;'><b><font size=2>Amended and Restated 1998 Stock Incentive Plan</font></b></p>

<p style=' margin-bottom:0pt; margin-top:0pt;text-align:center;'><b><font size=2>Amended and Restated 1998 Director Stock Plan</font></b></p>

<p style=' margin-bottom:0pt; margin-top:0pt;text-align:center;'><font size=2>(Full title of the plan)</font></p>

<p style=' margin-bottom:4pt; margin-top:0pt;text-align:center;'><font size=2>____________________</font></p>

<p style=' margin-bottom:0pt; margin-top:0pt;text-align:center;'><b><font size=2>Hyrum A. Mead</font></b></p>

<p style=' margin-bottom:0pt; margin-top:0pt;text-align:center;'><b><font size=2>President</font></b></p>

<p style=' margin-bottom:0pt; margin-top:0pt;text-align:center;'><b><font size=2>BSD Medical Corporation</font></b></p>

<p style=' margin-bottom:0pt; margin-top:0pt;text-align:center;'><font size=2>2188 West 2200</font><font size=2> South</font></p>

<p style=' margin-bottom:0pt; margin-top:0pt;text-align:center;'><font size=2>Salt Lake City, Utah  84119</font></p>

<p style=' margin-bottom:6pt; margin-top:0pt;text-align:center;'><font size=2>(801) 972-5555</font></p>

<p style=' margin-bottom:0pt; margin-top:0pt;text-align:center;'><font size=1>(Name, address and telephone number,</font></p>

<p style=' margin-bottom:0pt; margin-top:0pt;text-align:center;'><font size=1> including area code, of agent for service of process)</font></p>

<p style=' margin-bottom:4pt; margin-top:0pt;text-align:center;'><font size=2>____________________</font></p>

<p style=' margin-bottom:0pt; margin-top:0pt;text-align:center;'><font size=2>Copy to:</font></p>

<p style=' margin-bottom:0pt; margin-top:0pt;text-align:center;'><font size=2>Nolan S. Taylor</font></p>

<p style=' margin-bottom:0pt; margin-top:0pt;text-align:center;'><font size=2>Dorsey &amp; Whitney LLP</font></p>

<p style=' margin-bottom:0pt; margin-top:0pt;text-align:center;'><font size=2>136 South Main Street, Suite 1000</font></p>

<p style=' margin-bottom:0pt; margin-top:0pt;text-align:center;'><font size=2>Salt Lake City, Utah  84101</font></p>

<p style=' margin-bottom:0pt; margin-top:0pt;text-align:center;'><font size=2>(801) 933-7360</font></p>

<p style=' margin-bottom:12pt; margin-top:0pt;text-align:center;'><font size=2>____________________</font></p>

<p style=' margin-bottom:0pt; margin-top:0pt; text-indent:6.67%;text-align:left;'><font size=2>Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See the definitions of &#147;large accelerated filer,&#148; &#147;accelerated filer&#148; and &#147;smaller reporting company&#148; in Rule 12b-2 of the Exchange Act. (Check one):</font></p>
<BR>


<table border="0" cellspacing=0 cellpadding=0 width="80%" >
    <tr >
        <td width="20%" valign=top >
            <p style='margin-left:0pt;text-indent:0pt;text-align:left;margin-top:0pt;margin-bottom:0pt'><font size=2>&nbsp;</font></p> </td>

        <td width="30%" valign=top >
            <p style='margin-left:0pt;text-indent:0pt;text-align:left;margin-top:0pt;margin-bottom:0pt'><font size=2>Large accelerated filer &nbsp;&nbsp;&nbsp;</font><font face=Wingdings>o</font></p> </td>
        <td width="30%" valign=top >
            <p style='margin-left:0pt;text-indent:0pt;text-align:left;margin-top:0pt;margin-bottom:0pt'><font size=2>Accelerated filer &nbsp;&nbsp;&nbsp; </font><font face=Wingdings>x</font></p> </td> </tr>
    <tr >
        <td width="20%" valign=top >
            <p style='margin-left:0pt;text-indent:0pt;text-align:left;margin-top:0pt;margin-bottom:0pt'><font size=2>&nbsp;</font></p> </td>

        <td width="30%" valign=top >
            <p style='margin-left:0pt;text-indent:0pt;text-align:left;margin-top:0pt;margin-bottom:0pt'><font size=2>Non-accelerated filer  &nbsp;&nbsp;&nbsp;</font><font face=Wingdings>o</font></p> </td>
        <td width="30%" valign=top >
            <p style='margin-left:0pt;text-indent:0pt;text-align:left;margin-top:0pt;margin-bottom:0pt'><font size=2>Smaller reporting company  &nbsp;&nbsp;&nbsp;</font><font face=Wingdings>x</font></p> </td> </tr></table>

<p style=' margin-bottom:0pt; margin-top:0pt;text-align:center;'><font size=2>&nbsp;</font></p>
<BR>

<p style=' margin-bottom:0pt; margin-top:0pt;text-align:center;'><B><font SIZE=2>CALCULATION OF REGISTRATION FEE</font></B></p>


<table border="0" cellspacing=0 cellpadding=0 width="98%" style='margin-left:5.4pt;border-collapse:collapse;  '>
    <tr >
        <td width="22%" valign=bottom style='border-top:double black 2.25pt; border-left:none;border-bottom:solid black 1.0pt;border-right:none;  padding:0in 5.4pt 0in 5.4pt'>
            <p style='margin-left:0pt;text-indent:0pt;text-align:center;margin-top:0pt;margin-bottom:0pt'><font size=1>Title of securities to be registered</font></p> </td>
        <td width="2%" valign=bottom style='border-top:double black 2.25pt; border-left:none;border-bottom:solid black 1.0pt;border-right:none;  padding:0in 5.4pt 0in 5.4pt'>
            <p style='margin-left:0pt;text-indent:0pt;text-align:center;margin-top:0pt;margin-bottom:0pt'><font size=1>&nbsp;</font></p> </td>
        <td width="13%" valign=bottom style='border-top:double black 2.25pt; border-left:none;border-bottom:solid black 1.0pt;border-right:none;  padding:0in 5.4pt 0in 5.4pt'>
            <p style='margin-left:0pt;text-indent:0pt;text-align:center;margin-top:0pt;margin-bottom:0pt'><font size=1>Amount to</font><br> <font size=1>be registered(1)</font></p> </td>
        <td width="2%" valign=bottom style='border-top:double black 2.25pt; border-left:none;border-bottom:solid black 1.0pt;border-right:none;  padding:0in 5.4pt 0in 5.4pt'>
            <p style='margin-left:0pt;text-indent:0pt;text-align:center;margin-top:0pt;margin-bottom:0pt'><font size=1>&nbsp;</font></p> </td>
        <td width="18%" valign=bottom style='border-top:double black 2.25pt; border-left:none;border-bottom:solid black 1.0pt;border-right:none;  padding:0in 5.4pt 0in 5.4pt'>
            <p style='margin-left:0pt;text-indent:0pt;text-align:center;margin-top:0pt;margin-bottom:0pt'><font size=1>Proposed maximum</font><br> <font size=1>offering price per share</font></p> </td>
        <td width="2%" valign=bottom style='border-top:double black 2.25pt; border-left:none;border-bottom:solid black 1.0pt;border-right:none;  padding:0in 5.4pt 0in 5.4pt'>
            <p style='margin-left:0pt;text-indent:0pt;text-align:center;margin-top:0pt;margin-bottom:0pt'><font size=1>&nbsp;</font></p> </td>
        <td width="18%" valign=bottom style='border-top:double black 2.25pt; border-left:none;border-bottom:solid black 1.0pt;border-right:none;  padding:0in 5.4pt 0in 5.4pt'>
            <p style='margin-left:0pt;text-indent:0pt;text-align:center;margin-top:0pt;margin-bottom:0pt'><font size=1>Proposed maximum</font><br> <font size=1>aggregate offering price</font></p> </td>
        <td width="2%" valign=bottom style='border-top:double black 2.25pt; border-left:none;border-bottom:solid black 1.0pt;border-right:none;  padding:0in 5.4pt 0in 5.4pt'>
            <p style='margin-left:0pt;text-indent:0pt;text-align:center;margin-top:0pt;margin-bottom:0pt'><font size=1>&nbsp;</font></p> </td>
        <td width="18%" valign=bottom style='border-top:double black 2.25pt; border-left:none;border-bottom:solid black 1.0pt;border-right:none;  padding:0in 5.4pt 0in 5.4pt'>
            <p style='margin-left:0pt;text-indent:0pt;text-align:center;margin-top:0pt;margin-bottom:0pt'><font size=1>Amount of registration fee</font></p> </td> </tr>
    <tr style='height:26.05pt'>
        <td width="22%" valign=bottom style='border-bottom: solid black 1.0pt;padding: 0in 5.4pt 0in 5.4pt;height:26.05pt'>
            <p style='margin-left:0pt;text-indent:0pt;text-align:left;margin-top:0pt;margin-bottom:0pt'><font size=1>Common Stock, $0.001</font></p>
<p style='margin-left:0pt;text-indent:0pt;text-align:left;margin-top:0pt;margin-bottom:0pt'><font size=1>par value per share, issuable pursuant to the Amended and Restated 1998 Stock Incentive Plan</font></p> </td>
        <td width="2%" valign=bottom style='border-bottom: solid black 1.0pt;padding: 0in 5.4pt 0in 5.4pt;height:26.05pt'>
            <p style='margin-left:0pt;text-indent:0pt;text-align:left;margin-top:0pt;margin-bottom:0pt'><font size=1>&nbsp;</font></p> </td>
        <td width="13%" valign=bottom style='border-bottom: solid black 1.0pt;padding: 0in 5.4pt 0in 5.4pt;height:26.05pt'>
            <p style='margin-left:0pt;text-indent:0pt;text-align:center;margin-top:0pt;margin-bottom:0pt'><font size=1>750,000</font></p> </td>
        <td width="2%" valign=bottom style='border-bottom: solid black 1.0pt;padding: 0in 5.4pt 0in 5.4pt;height:26.05pt'>
            <p style='margin-left:0pt;text-indent:0pt;text-align:center;margin-top:0pt;margin-bottom:0pt'><font size=1>&nbsp;</font></p> </td>
        <td width="18%" valign=bottom style='border-bottom: solid black 1.0pt;padding: 0in 5.4pt 0in 5.4pt;height:26.05pt'>
            <p style='margin-left:0pt;text-indent:0pt;text-align:center;margin-top:0pt;margin-bottom:0pt'><font size=1>$3.54(2)</font></p> </td>
        <td width="2%" valign=bottom style='border-bottom: solid black 1.0pt;padding: 0in 5.4pt 0in 5.4pt;height:26.05pt'>
            <p style='margin-left:0pt;text-indent:0pt;text-align:center;margin-top:0pt;margin-bottom:0pt'><font size=1>&nbsp;</font></p> </td>
        <td width="18%" valign=bottom style='border-bottom: solid black 1.0pt;padding: 0in 5.4pt 0in 5.4pt;height:26.05pt'>
            <p style='margin-left:0pt;text-indent:0pt;text-align:center;margin-top:0pt;margin-bottom:0pt'><font size=1>$2,655,500(2)</font></p> </td>
        <td width="2%" valign=bottom style='border-bottom: solid black 1.0pt;padding: 0in 5.4pt 0in 5.4pt;height:26.05pt'>
            <p style='margin-left:0pt;text-indent:0pt;text-align:center;margin-top:0pt;margin-bottom:0pt'><font size=1>&nbsp;</font></p> </td>
        <td width="18%" valign=bottom style='border-bottom: solid black 1.0pt;padding: 0in 5.4pt 0in 5.4pt;height:26.05pt'>
            <p style='margin-left:0pt;text-indent:0pt;text-align:center;margin-top:0pt;margin-bottom:0pt'><font size=1>$104.36</font></p> </td> </tr>
    <tr style='height:26.05pt'>
        <td width="22%" valign=bottom style='border-bottom: solid black 1.0pt;padding: 0in 5.4pt 0in 5.4pt;height:26.05pt'>
            <p style='margin-left:0pt;text-indent:0pt;text-align:left;margin-top:0pt;margin-bottom:0pt'><font size=1>Common Stock, $0.001</font></p>
<p style='margin-left:0pt;text-indent:0pt;text-align:left;margin-top:0pt;margin-bottom:0pt'><font size=1>par value per share, issuable pursuant to the Amended and Restated 1998 Director Stock Plan</font></p> </td>
        <td width="2%" valign=bottom style='border-bottom: solid black 1.0pt;padding: 0in 5.4pt 0in 5.4pt;height:26.05pt'>
            <p style='margin-left:0pt;text-indent:0pt;text-align:left;margin-top:0pt;margin-bottom:0pt'><font size=1>&nbsp;</font></p> </td>
        <td width="13%" valign=bottom style='border-bottom: solid black 1.0pt;padding: 0in 5.4pt 0in 5.4pt;height:26.05pt'>
            <p style='margin-left:0pt;text-indent:0pt;text-align:center;margin-top:0pt;margin-bottom:0pt'><font size=1>885,278</font></p> </td>
        <td width="2%" valign=bottom style='border-bottom: solid black 1.0pt;padding: 0in 5.4pt 0in 5.4pt;height:26.05pt'>
            <p style='margin-left:0pt;text-indent:0pt;text-align:center;margin-top:0pt;margin-bottom:0pt'><font size=1>&nbsp;</font></p> </td>
        <td width="18%" valign=bottom style='border-bottom: solid black 1.0pt;padding: 0in 5.4pt 0in 5.4pt;height:26.05pt'>
            <p style='margin-left:0pt;text-indent:0pt;text-align:center;margin-top:0pt;margin-bottom:0pt'><font size=1>$4.36(3)</font></p> </td>
        <td width="2%" valign=bottom style='border-bottom: solid black 1.0pt;padding: 0in 5.4pt 0in 5.4pt;height:26.05pt'>
            <p style='margin-left:0pt;text-indent:0pt;text-align:center;margin-top:0pt;margin-bottom:0pt'><font size=1>&nbsp;</font></p> </td>
        <td width="18%" valign=bottom style='border-bottom: solid black 1.0pt;padding: 0in 5.4pt 0in 5.4pt;height:26.05pt'>
            <p style='margin-left:0pt;text-indent:0pt;text-align:center;margin-top:0pt;margin-bottom:0pt'><font size=1>$3,860,055(3)</font></p> </td>
        <td width="2%" valign=bottom style='border-bottom: solid black 1.0pt;padding: 0in 5.4pt 0in 5.4pt;height:26.05pt'>
            <p style='margin-left:0pt;text-indent:0pt;text-align:center;margin-top:0pt;margin-bottom:0pt'><font size=1>&nbsp;</font></p> </td>
        <td width="18%" valign=bottom style='border-bottom: solid black 1.0pt;padding: 0in 5.4pt 0in 5.4pt;height:26.05pt'>
            <p style='margin-left:0pt;text-indent:0pt;text-align:center;margin-top:0pt;margin-bottom:0pt'><font size=1>$151.70</font></p> </td> </tr>
    <tr style='height:26.05pt'>
        <td width="22%" valign=bottom style='border-bottom: double black 2.25pt;padding:0in 5.4pt 0in 5.4pt; height:26.05pt'>
            <p style='margin-left:0pt;text-indent:0pt;text-align:left;margin-top:0pt;margin-bottom:0pt'><font size=1>Total</font></p> </td>
        <td width="2%" valign=bottom style='border-bottom: double black 2.25pt;padding:0in 5.4pt 0in 5.4pt; height:26.05pt'>
            <p style='margin-left:0pt;text-indent:0pt;text-align:left;margin-top:0pt;margin-bottom:0pt'><font size=1>&nbsp;</font></p> </td>
        <td width="13%" valign=bottom style='border-bottom: double black 2.25pt;padding:0in 5.4pt 0in 5.4pt; height:26.05pt'>
            <p style='margin-left:0pt;text-indent:0pt;text-align:center;margin-top:0pt;margin-bottom:0pt'><font size=1>1,635,278</font></p> </td>
        <td width="2%" valign=bottom style='border-bottom: double black 2.25pt;padding:0in 5.4pt 0in 5.4pt; height:26.05pt'>
            <p style='margin-left:0pt;text-indent:0pt;text-align:center;margin-top:0pt;margin-bottom:0pt'><font size=1>&nbsp;</font></p> </td>
        <td width="18%" valign=bottom style='border-bottom: double black 2.25pt;padding:0in 5.4pt 0in 5.4pt; height:26.05pt'>
            <p style='margin-left:0pt;text-indent:0pt;text-align:center;margin-top:0pt;margin-bottom:0pt'><font size=1>&nbsp;</font></p> </td>
        <td width="2%" valign=bottom style='border-bottom: double black 2.25pt;padding:0in 5.4pt 0in 5.4pt; height:26.05pt'>
            <p style='margin-left:0pt;text-indent:0pt;text-align:center;margin-top:0pt;margin-bottom:0pt'><font size=1>&nbsp;</font></p> </td>
        <td width="18%" valign=bottom style='border-bottom: double black 2.25pt;padding:0in 5.4pt 0in 5.4pt; height:26.05pt'>
            <p style='margin-left:0pt;text-indent:0pt;text-align:center;margin-top:0pt;margin-bottom:0pt'><font size=1>$6,515,555</font></p> </td>
        <td width="2%" valign=bottom style='border-bottom: double black 2.25pt;padding:0in 5.4pt 0in 5.4pt; height:26.05pt'>
            <p style='margin-left:0pt;text-indent:0pt;text-align:center;margin-top:0pt;margin-bottom:0pt'><font size=1>&nbsp;</font></p> </td>
        <td width="18%" valign=bottom style='border-bottom: double black 2.25pt;padding:0in 5.4pt 0in 5.4pt; height:26.05pt'>
            <p style='margin-left:0pt;text-indent:0pt;text-align:center;margin-top:0pt;margin-bottom:0pt'><font size=1>$256.06</font></p> </td> </tr></table>
<BR>





<table border="0" cellspacing=0 cellpadding=0 width="100%" style='border-collapse:collapse'>
    <tr >
        <td width="3%" valign=top style='padding:3.0pt 0in 12.0pt 0in'>
            <p style='margin-left:0pt;text-indent:0pt;text-align:left;margin-top:0pt;margin-bottom:0pt'><font size=1>(1)</font></p> </td>
        <td  valign=top style='padding:3.0pt 0in 12.0pt 0in'>
            <p style='margin-left:0pt;text-indent:0pt;text-align:left;margin-top:0pt;margin-bottom:0pt'><font size=1>This Registration Statement shall also cover any additional shares of the Registrant&#146;s common stock that become issuable by reason of any stock dividend, stock split, recapitalization or any other similar transaction effected without the Registrant&#146;s receipt of consideration which results in an increase in the number of outstanding shares of the Registrant&#146;s common stock.</font></p> </td> </tr></table>



<table border="0" cellspacing=0 cellpadding=0 width="100%" style='border-collapse:collapse'>
    <tr >
        <td width="3%" valign=top style='padding:3.0pt 0in 12.0pt 0in'>
            <p style='margin-left:0pt;text-indent:0pt;text-align:left;margin-top:0pt;margin-bottom:0pt'><font size=1>(2)</font></p> </td>
        <td  valign=top style='padding:3.0pt 0in 12.0pt 0in'>
            <p style='margin-left:0pt;text-indent:0pt;text-align:left;margin-top:0pt;margin-bottom:0pt'><font size=1>Estimated solely for the purpose of calculating the registration fee in accordance with Rule&nbsp;457(h)(1) and Rule&nbsp;457(c) of the Securities Act of&nbsp;1933, as amended. The proposed maximum aggregate offering price has been calculated as follows: options to purchase 175,000 shares of Common Stock have been granted with an exercise price of&nbsp;$5.81; the proposed maximum aggregate offering price of the remaining 575,000 shares of Common Stock that are being registered herein is based upon the average of the high and low prices of the registrant&#146;s Common Stock as reported on the Nasdaq Stock Market&#146;s consolidated reporting system on January 23, 2009.</font></p> </td> </tr></table>



<table border="0" cellspacing=0 cellpadding=0 width="100%" style='border-collapse:collapse'>
    <tr >
        <td width="3%" valign=top style='padding:3.0pt 0in 12.0pt 0in'>
            <p style='margin-left:0pt;text-indent:0pt;text-align:left;margin-top:0pt;margin-bottom:0pt'><font size=1>(3)</font></p> </td>
        <td  valign=top style='padding:3.0pt 0in 12.0pt 0in'>
            <p style='margin-left:0pt;text-indent:0pt;text-align:left;margin-top:0pt;margin-bottom:0pt'><font size=1>Estimated solely for the purpose of calculating the registration fee in accordance with Rule&nbsp;457(h)(1) and Rule&nbsp;457(c) of the Securities Act of&nbsp;1933, as amended. The proposed maximum aggregate offering price has been calculated as follows: options to purchase 573,825 shares of Common Stock have been granted with an exercise price of&nbsp;$5.18; the proposed maximum aggregate offering price of the remaining 311,453 shares of Common Stock that are being registered herein is based upon the average of the high and low prices of the registrant&#146;s Common Stock as reported on the Nasdaq Stock Market&#146;s consolidated reporting system on January 23, 2009.</font></p> </td> </tr></table>


<p style=' margin-bottom:0pt; margin-top:0pt;text-align:left;'><font size=2>&nbsp;</font></p>

<p style='page-break-before:always'></p>

<p style=' margin-bottom:0pt; margin-top:0pt;text-align:left;'><font size=2>&nbsp;</font></p>

<p style=' margin-bottom:0pt; margin-top:0pt;text-align:left;'><font size=2>&nbsp;</font></p>


<p style=' margin-bottom:0pt; margin-top:0pt;text-align:left;'><font size=2>&nbsp;</font></p>





<HR SIZE=2 COLOR=black NOSHADE>



<p style=' margin-bottom:0pt; margin-top:0pt;text-align:left;'><font size=2>&nbsp;</font></p>

<p style=' margin-bottom:0pt; margin-top:0pt;text-align:left;'><font size=2>&nbsp;</font></p>


<p style=' margin-bottom:12pt; margin-top:0pt;text-align:center;'><B><font SIZE=3>PART I</font></B></p>

<p style=' margin-bottom:0pt; margin-top:0pt;text-align:center;'>&nbsp;</p>

<p style=' margin-bottom:12pt; margin-top:0pt;text-align:center;'><B><font SIZE=3>INFORMATION REQUIRED IN THE SECTION 10(A) PROSPECTUS</font></B></p>


<table border="0" cellspacing=0 cellpadding=0 width="100%" style='border-collapse:collapse'>
    <tr >
        <td width="7%" nowrap valign=top style='padding:0in 0in 12.0pt 0in; '>
            <p style='margin-left:0pt;text-indent:0pt;text-align:left;margin-top:0pt;margin-bottom:0pt'><b><font size=2>Item 1.</font></b></p> </td>
        <td nowrap valign=top style='padding:0in 0in 12.0pt 0in; '>
            <p style='margin-left:0pt;text-indent:0pt;text-align:left;margin-top:0pt;margin-bottom:0pt'><b><font size=2>Plan Information.</font></b></p> </td> </tr></table>

<p style=' margin-bottom:12pt; margin-top:0pt; text-indent:7.0%;text-align:left;'><font size=2>Information required by Item 1 to be contained in the Section 10(a) prospectus is omitted from this Registration Statement in accordance with Rule 428 adopted under the Securities Act of 1933, as amended (the &#147;Securities Act&#148;), and the Note to Part I of Form S-8.</font></p>


<table border="0" cellspacing=0 cellpadding=0 width="100%" style='border-collapse:collapse'>
    <tr >
        <td width="7%" nowrap valign=top style='padding:0in 0in 12.0pt 0in; '>
            <p style='margin-left:0pt;text-indent:0pt;text-align:left;margin-top:0pt;margin-bottom:0pt'><b><font size=2>Item 2.</font></b></p> </td>
        <td nowrap valign=top style='padding:0in 0in 12.0pt 0in; '>
            <p style='margin-left:0pt;text-indent:0pt;text-align:left;margin-top:0pt;margin-bottom:0pt'><b><font size=2>Registrant Information and Employee Plan Annual Information.</font></b></p> </td> </tr></table>

<p style=' margin-bottom:12pt; margin-top:0pt; text-indent:7.54%;text-align:left;'><font size=2>Information required by Item 2 to be contained in the Section 10(a) prospectus is omitted from this Registration Statement in accordance with Rule 428 adopted under the Securities Act and the Note to Part I of Form S-8.</font></p>

<p style=' margin-bottom:0pt; margin-top:0pt;text-align:center;'><B><font SIZE=3>PART II</font></B></p>

<p style=' margin-bottom:0pt; margin-top:0pt;text-align:center;'><font size=3>&nbsp;</font></p>

<p style=' margin-bottom:28pt; margin-top:0pt;text-align:center;'><B><font SIZE=3>INFORMATION REQUIRED IN THE REGISTRATION STATEMENT</font></B></p>


<table border="0" cellspacing=0 cellpadding=0 width="100%" style='border-collapse:collapse'>
    <tr >
        <td width="7%" valign=top style='padding:0in 0in 12.0pt 0in'>
            <p style='margin-left:0pt;text-indent:0pt;text-align:left;margin-top:0pt;margin-bottom:0pt'><b><font size=2>Item 3.</font></b></p> </td>
        <td valign=top style='padding:0in 0in 12.0pt 0in'>
            <p style='margin-left:0pt;text-indent:0pt;text-align:left;margin-top:0pt;margin-bottom:0pt'><b><font size=2>Incorporation of Documents by Reference.</font></b></p> </td> </tr></table>

<p style=' margin-bottom:12pt; margin-top:0pt; text-indent:7.0%;text-align:left;'><font size=2>The following documents, which have been filed with the Securities and Exchange Commission (the &#147;Commission&#148;) by&nbsp;BSD Medical Corporation (the &#147;Company&#148;), are incorporated by reference in this Registration Statement, as of their respective dates:</font></p>


<table border="0" cellspacing=0 cellpadding=0 width="100%" style='margin-left:0pt;border-collapse:collapse'>
    <tr >
        <td width="7%" valign=top style='padding:0in 0in 12.0pt 0in'>
            <p style='margin-left:0pt;text-indent:0pt;text-align:left;margin-top:0pt;margin-bottom:12pt'><font size=1>&nbsp;</font></p> </td>
        <td width="7%" valign=top style='padding:0in 0in 12.0pt 0in'>
            <p style='margin-left:0pt;text-indent:0pt;text-align:left;margin-top:0pt;margin-bottom:0pt'><font size=2>(a)</font></p> </td>
        <td  valign=top style='padding:0in 0in 12.0pt 0in'>
            <p style='margin-left:0pt;text-indent:0pt;text-align:left;margin-top:0pt;margin-bottom:0pt'><font size=2>the Company&#146;s Annual Report on Form&nbsp;10-K for the fiscal year ended August&nbsp;31,&nbsp;2008;</font></p> </td> </tr></table>



<table border="0" cellspacing=0 cellpadding=0 width="100%" style='margin-left:0pt;border-collapse:collapse'>
    <tr >
        <td width="7%" valign=top style='padding:0in 0in 12.0pt 0in'>
            <p style='margin-left:0pt;text-indent:0pt;text-align:left;margin-top:0pt;margin-bottom:12pt'><font size=1>&nbsp;</font></p> </td>
        <td width="7%" valign=top style='padding:0in 0in 12.0pt 0in'>
            <p style='margin-left:0pt;text-indent:0pt;text-align:left;margin-top:0pt;margin-bottom:0pt'><font size=2>(b)</font></p> </td>
        <td  valign=top style='padding:0in 0in 12.0pt 0in'>
            <p style='margin-left:0pt;text-indent:0pt;text-align:left;margin-top:0pt;margin-bottom:0pt'><font size=2>the Company&#146;s Quarterly Report on Form&nbsp;10-Q for the quarter ended November 30,&nbsp;2008;</font></p> </td> </tr></table>



<table border="0" cellspacing=0 cellpadding=0 width="100%" style='margin-left:0pt;border-collapse:collapse'>
    <tr >
        <td width="7%" valign=top style='padding:0in 0in 12.0pt 0in'>
            <p style='margin-left:0pt;text-indent:0pt;text-align:left;margin-top:0pt;margin-bottom:12pt'><font size=1>&nbsp;</font></p> </td>
        <td width="7%" valign=top style='padding:0in 0in 12.0pt 0in'>
            <p style='margin-left:0pt;text-indent:0pt;text-align:left;margin-top:0pt;margin-bottom:0pt'><font size=2>(c)</font></p> </td>
        <td  valign=top style='padding:0in 0in 12.0pt 0in'>
            <p style='margin-left:0pt;text-indent:0pt;text-align:left;margin-top:0pt;margin-bottom:0pt'><font size=2>the Company&#146;s Current Reports on Form 8-K filed on September 11, 2008 and Form 8-K/A filed on September 9, 2008; and </font></p> </td> </tr></table>



<table border="0" cellspacing=0 cellpadding=0 width="100%" style='border-collapse:collapse'>
    <tr >
        <td width="7%" valign=top style='padding:0in 0in 12.0pt 0in'>
            <p style='margin-left:0pt;text-indent:0pt;text-align:left;margin-top:0pt;margin-bottom:12pt'><font size=1>&nbsp;</font></p> </td>
        <td width="7%" valign=top style='padding:0in 0in 12.0pt 0in'>
            <p style='margin-left:0pt;text-indent:0pt;text-align:left;margin-top:0pt;margin-bottom:0pt'><font size=2>(d)</font></p> </td>
        <td  valign=top style='padding:0in 0in 12.0pt 0in'>
            <p style='margin-left:0pt;text-indent:0pt;text-align:left;margin-top:0pt;margin-bottom:0pt'><font size=2>the description of the Company&#146;s Common Stock, par value&nbsp;$0.001 per share, as contained in Item&nbsp;1 of the Registration Statement on Form&nbsp;8-A filed on April&nbsp;22,&nbsp;2008, including any amendment or report filed for the purpose of updating such description filed for the purpose of updating such description.</font></p> </td> </tr></table>


<p style=' margin-bottom:12pt; margin-top:0pt; text-indent:7.0%;text-align:left;'><font size=2>All documents filed by the Company pursuant to Sections&nbsp;13(a), 13(c), 14 and&nbsp;15(d) of the Securities Exchange Act of&nbsp;1934, as amended, subsequent to the date hereof and prior to the filing of a post-effective amendment which indicates that all securities offered hereby have been sold or which deregisters all securities remaining unsold shall be deemed to be incorporated by reference herein and to be a part hereof from the respective dates of filing of such documents.</font></p>

<p style=' margin-bottom:0pt; margin-top:0pt;text-align:left;'><font size=2>&nbsp;</font></p>

<p style=' margin-bottom:0pt; margin-top:0pt;text-align:left;'><font size=2>&nbsp;</font></p>


<!-- MARKER FORMAT-SHEET="Para Default" FSL="Default" -->
<P align=center><FONT FACE="Times New Roman, Times, Serif" SIZE=2>II-1 </FONT></P>
<BR>


<HR SIZE=2 COLOR=black NOSHADE>



<p style='page-break-before:always'></p>

<p style=' margin-bottom:0pt; margin-top:0pt;text-align:left;'><font size=2>&nbsp;</font></p>

<p style=' margin-bottom:0pt; margin-top:0pt;text-align:left;'><font size=2>&nbsp;</font></p>


<table border="0" cellspacing=0 cellpadding=0 width="100%" style='border-collapse:collapse'>
    <tr >
        <td width="7%" nowrap valign=top style='padding:0in 0in 12.0pt 0in; '>
            <p style='margin-left:0pt;text-indent:0pt;text-align:left;margin-top:0pt;margin-bottom:0pt'><b><font size=2>Item 4.</font></b></p> </td>
        <td nowrap valign=top style='padding:0in 0in 12.0pt 0in; '>
            <p style='margin-left:0pt;text-indent:0pt;text-align:left;margin-top:0pt;margin-bottom:0pt'><b><font size=2>Description of Securities.</font></b></p> </td> </tr></table>

<p style=' margin-bottom:12pt; margin-top:0pt; text-indent:7.0%;text-align:left;'><font size=2>Not applicable.</font></p>


<table border="0" cellspacing=0 cellpadding=0 width="100%" style='border-collapse:collapse'>
    <tr >
        <td width="7%" nowrap valign=top style='padding:0in 0in 12.0pt 0in; '>
            <p style='margin-left:0pt;text-indent:0pt;text-align:left;margin-top:0pt;margin-bottom:0pt'><b><font size=2>Item 5.</font></b></p> </td>
        <td nowrap valign=top style='padding:0in 0in 12.0pt 0in; '>
            <p style='margin-left:0pt;text-indent:0pt;text-align:left;margin-top:0pt;margin-bottom:0pt'><b><font size=2>Interests of Named Experts and Counsel.</font></b></p> </td> </tr></table>

<p style=' margin-bottom:12pt; margin-top:0pt; text-indent:7.0%;text-align:left;'><font size=2>Not applicable.</font></p>


<table border="0" cellspacing=0 cellpadding=0 width="100%" style='border-collapse:collapse'>
    <tr >
        <td width="7%" nowrap valign=top style='padding:0in 0in 12.0pt 0in; '>
            <p style='margin-left:0pt;text-indent:0pt;text-align:left;margin-top:0pt;margin-bottom:0pt'><b><font size=2>Item 6.</font></b></p> </td>
        <td nowrap valign=top style='padding:0in 0in 12.0pt 0in; '>
            <p style='margin-left:0pt;text-indent:0pt;text-align:left;margin-top:0pt;margin-bottom:0pt'><b><font size=2>Indemnification of Directors and Officers.</font></b></p> </td> </tr></table>

<p style=' margin-bottom:12pt; margin-top:0pt; text-indent:7.0%;text-align:left;'><i><b><font size=2>Indemnification</font></b></i></p>

<p style=' margin-bottom:12pt; margin-top:0pt; text-indent:7.0%;text-align:left;'><font size=2>Section&nbsp;145 of the Delaware General Corporation Law grants the Company the power to indemnify its officers and directors, under certain circumstances and subject to certain conditions and limitations as stated therein, against all expenses and liabilities incurred by or imposed upon them as a result of suits brought against them as such officers and directors if they act in good faith and in a manner they reasonably believe to be in or not opposed to the best interests of the Company, and, with respect to any criminal action or proceeding, have no reasonable cause to believe their conduct was unlawful.</font></p>

<p style=' margin-bottom:12pt; margin-top:0pt; text-indent:7.0%;text-align:left;'><font size=2>Section&nbsp;145 of the Delaware General Corporation Law permits a corporation to include in its charter documents, and in agreements between the corporation and its directors and officers, provisions expanding the scope of indemnification beyond that specifically provided by the current law.</font></p>

<p style=' margin-bottom:12pt; margin-top:0pt; text-indent:7.0%;text-align:left;'><font size=2>Article&nbsp;8 of the Company&#146;s Amended and Restated Certificate of Incorporation provides for the indemnification of directors to the fullest extent permissible under Delaware law.</font></p>

<p style=' margin-bottom:12pt; margin-top:0pt; text-indent:7.0%;text-align:left;'><font size=2>Section&nbsp;8 of Article&nbsp;IX of the Company&#146;s Bylaws provides for the indemnification of officers, directors and third parties acting on behalf of the Company if such person acted in good faith and in a manner reasonably believed to be in, and not opposed to, the Company&#146;s best interest, and, with respect to any criminal action or proceeding, the indemnified party had no reason to believe his or her conduct was unlawful.</font></p>

<p style=' margin-bottom:12pt; margin-top:0pt; text-indent:7.0%;text-align:left;'><i><b><font size=2>Liability Insurance</font></b></i><b><font size=2> </font></b></p>

<p style=' margin-bottom:12pt; margin-top:0pt; text-indent:7.0%;text-align:left;'><font size=2>Section&nbsp;145 of the Delaware General Corporation Law also permits a Delaware corporation to purchase and maintain insurance on behalf of its directors and officers. The Company&#146;s  bylaws permit the registrant to purchase such insurance on behalf of its directors and officers. The Company maintains a policy of liability insurance for its officers and directors.</font></p>


<table border="0" cellspacing=0 cellpadding=0 width="100%" style='border-collapse:collapse'>
    <tr >
        <td width="7%" nowrap valign=top style='padding:0in 0in 12.0pt 0in; '>
            <p style='margin-left:0pt;text-indent:0pt;text-align:left;margin-top:0pt;margin-bottom:0pt'><b><font size=2>Item 7.</font></b></p> </td>
        <td nowrap valign=top style='padding:0in 0in 12.0pt 0in; '>
            <p style='margin-left:0pt;text-indent:0pt;text-align:left;margin-top:0pt;margin-bottom:0pt'><b><font size=2>Exemption from Registration Claimed.</font></b></p> </td> </tr></table>

<p style=' margin-bottom:12pt; margin-top:0pt; text-indent:7.0%;text-align:left;'><font size=2>Not applicable.</font></p>

<p style=' margin-bottom:0pt; margin-top:0pt;text-align:left;'><font size=2>&nbsp;</font></p>

<p style=' margin-bottom:0pt; margin-top:0pt;text-align:left;'><font size=2>&nbsp;</font></p>

<!-- MARKER FORMAT-SHEET="Para Default" FSL="Default" -->
<P align=center><FONT FACE="Times New Roman, Times, Serif" SIZE=2>II-2 </FONT></P>
<BR>




<HR SIZE=2 COLOR=black NOSHADE>



<p style='page-break-before:always'></p>

<p style=' margin-bottom:0pt; margin-top:0pt;text-align:left;'><font size=2>&nbsp;</font></p>

<p style=' margin-bottom:0pt; margin-top:0pt;text-align:left;'><font size=2>&nbsp;</font></p>


<table border="0" cellspacing=0 cellpadding=0 width="100%" style='border-collapse:collapse'>
    <tr >
        <td width="7%" nowrap valign=top style='padding:0in 0in 12.0pt 0in; '>
            <p style='margin-left:0pt;text-indent:0pt;text-align:left;margin-top:0pt;margin-bottom:0pt'><b><font size=2>Item 8.</font></b></p> </td>
        <td nowrap valign=top style='padding:0in 0in 12.0pt 0in; '>
            <p style='margin-left:0pt;text-indent:0pt;text-align:left;margin-top:0pt;margin-bottom:0pt'><b><font size=2>Exhibits.</font></b></p> </td> </tr></table>

<table width="100%" border="0" cellspacing=0 cellpadding=0 style='border-collapse:collapse'>
    <tr style='page-break-inside:avoid;height:.5in'>
        <td width="86" valign=bottom style='border-bottom: solid black 1.0pt; height:.5in'>
            <p style='margin-left:0pt;text-indent:0pt;text-align:center;margin-top:0pt;margin-bottom:0pt'><b><font size=2>Exhibit</font></b><br> <b><font size=2>Number</font></b></p> </td>
        <td width="19" valign=bottom style=' height:.5in'>
            <p style='margin-left:0pt;text-indent:0pt;text-align:center;margin-top:1.0pt;margin-bottom:0pt'><font size=1>&nbsp;</font></p> </td>
        <td width="518" valign=bottom style='border-bottom: solid black 1.0pt; height:.5in'>
            <p style='margin-left:0pt;text-indent:0pt;text-align:center;margin-top:0pt;margin-bottom:0pt'><b><font size=2>Description</font></b></p> </td> </tr>
    <tr style='page-break-inside:avoid;height:.25in'>
        <td width="86" valign=top style='height:.25in'>
            <p style='margin-left:0in;text-indent:0pt;text-align:center;margin-top:2.0pt;margin-bottom:2.0pt'><font size=2>4.1</font></p> </td>
        <td width="19" valign=top style=' height:.25in'>
            <p style='margin-left:0in;text-indent:0pt;text-align:left;margin-top:2.0pt;margin-bottom: 2.0pt'><font size=1>&nbsp;</font></p> </td>
        <td width="518" valign=top style='height:.25in'>
            <p style='margin-left:0in;text-indent:0pt;text-align:left;margin-top:2.0pt;margin-bottom: 2.0pt'><font size=2>Amended and Restated Certificate of Incorporation. Incorporated by reference to Exhibit&nbsp;3.1 of the&nbsp;BSD Medical Corporation Form&nbsp;10-KSB filed December&nbsp;1,&nbsp;2003 (File Number&nbsp;000-10783).</font></p> </td> </tr>
    <tr style='page-break-inside:avoid;height:.25in'>
        <td width="86" valign=top style=' height:.25in'>
            <p style='margin-left:0in;text-indent:0pt;text-align:center;margin-top:2.0pt;margin-bottom:2.0pt'><font size=2>4.2</font></p> </td>
        <td width="19" valign=top style=' height:.25in'>
            <p style='margin-left:0in;text-indent:0pt;text-align:left;margin-top:2.0pt;margin-bottom: 2.0pt'><font size=1>&nbsp;</font></p> </td>
        <td width="518" valign=top style=' height:.25in'>
            <p style='margin-left:0in;text-indent:0pt;text-align:left;margin-top:2.0pt;margin-bottom: 2.0pt'><font size=2>Bylaws. Incorporated by reference to Exhibit&nbsp;3.2 of the&nbsp;BSD Medical Corporation Registration Statement on Form S-1, filed October&nbsp;16,&nbsp;1986 (File Number&nbsp;033-09534).</font></p> </td> </tr>
    <tr style='page-break-inside:avoid;height:.25in'>
        <td width="86" valign=top style=' height:.25in'>
            <p style='margin-left:0in;text-indent:0pt;text-align:center;margin-top:2.0pt;margin-bottom:2.0pt'><font size=2>4.3</font></p> </td>
        <td width="19" valign=top style=' height:.25in'>
            <p style='margin-left:0in;text-indent:0pt;text-align:left;margin-top:2.0pt;margin-bottom: 2.0pt'><font size=1>&nbsp;</font></p> </td>
        <td width="518" valign=top style=' height:.25in'>
            <p style='margin-left:0in;text-indent:0pt;text-align:left;margin-top:2.0pt;margin-bottom: 2.0pt'><font size=2>Amendment to Bylaws. Incorporated by reference to Exhibit 3.1 of the BSD Medical Corporation Current Report on Form 8-K, filed January 4, 2008 (File Number&nbsp;001-32526).</font></p> </td> </tr>
    <tr style='page-break-inside:avoid;height:.25in'>
        <td width="86" valign=top style=' height:.25in'>
            <p style='margin-left:0in;text-indent:0pt;text-align:center;margin-top:2.0pt;margin-bottom:2.0pt'><font size=2>4.4</font></p> </td>
        <td width="19" valign=top style=' height:.25in'>
            <p style='margin-left:0in;text-indent:0pt;text-align:left;margin-top:2.0pt;margin-bottom: 2.0pt'><font size=1>&nbsp;</font></p> </td>
        <td width="518" valign=top style=' height:.25in'>
            <p style='margin-left:0in;text-indent:0pt;text-align:left;margin-top:2.0pt;margin-bottom: 2.0pt'><font size=2>Specimen Common Stock Certificate. Incorporated by reference to Exhibit&nbsp;4 of the&nbsp;BSD Medical Corporation Registration Statement on Form&nbsp;S-1, filed October&nbsp;16,&nbsp;1986 (File Number&nbsp;033-09534).</font></p> </td> </tr>
    <tr style='page-break-inside:avoid;height:.25in'>
        <td width="86" valign=top style=' height:.25in'>
            <p style='margin-left:0in;text-indent:0pt;text-align:center;margin-top:2.0pt;margin-bottom:2.0pt'><font size=2>5.1</font></p> </td>
        <td width="19" valign=top style=' height:.25in'>
            <p style='margin-left:0in;text-indent:0pt;text-align:left;margin-top:2.0pt;margin-bottom: 2.0pt'><font size=1>&nbsp;</font></p> </td>
        <td width="518" valign=top style=' height:.25in'>
            <p style='margin-left:0in;text-indent:0pt;text-align:left;margin-top:2.0pt;margin-bottom: 2.0pt'><font size=2>Opinion of Dorsey&nbsp;&amp; Whitney LLP.</font></p> </td> </tr>
    <tr style='page-break-inside:avoid;height:.25in'>
        <td width="86" valign=top style=' height:.25in'>
            <p style='margin-left:0in;text-indent:0pt;text-align:center;margin-top:2.0pt;margin-bottom:2.0pt'><font size=2>10.1</font></p> </td>
        <td width="19" valign=top style=' height:.25in'>
            <p style='margin-left:0in;text-indent:0pt;text-align:left;margin-top:2.0pt;margin-bottom: 2.0pt'><font size=1>&nbsp;</font></p> </td>
        <td width="518" valign=top style=' height:.25in'>
            <p style='margin-left:0in;text-indent:0pt;text-align:left;margin-top:2.0pt;margin-bottom: 2.0pt'><font size=2>BSD Medical Corporation Second Amended and Restated 1998 Stock Incentive Plan. Incorporated by reference to Appendix&nbsp;B of the BSD Medical Corporation Proxy Statement, filed January&nbsp;3,&nbsp;2008 (File No.&nbsp;001-32526).</font></p> </td> </tr>
    <tr style='page-break-inside:avoid;height:.25in'>
        <td width="86" valign=top style=' height:.25in'>
            <p style='margin-left:0in;text-indent:0pt;text-align:center;margin-top:2.0pt;margin-bottom:2.0pt'><font size=2>10.2</font></p> </td>
        <td width="19" valign=top style=' height:.25in'>
            <p style='margin-left:0in;text-indent:0pt;text-align:left;margin-top:2.0pt;margin-bottom: 2.0pt'><font size=1>&nbsp;</font></p> </td>
        <td width="518" valign=top style=' height:.25in'>
            <p style='margin-left:0in;text-indent:0pt;text-align:left;margin-top:2.0pt;margin-bottom: 2.0pt'><font size=2>BSD Medical Corporation Second Amended and Restated 1998 Director Stock Plan. Incorporated by reference to Appendix&nbsp;A of the BSD Medical Corporation Proxy Statement, filed January&nbsp;3,&nbsp;2008 (File No.&nbsp;001-32526). </font></p> </td> </tr>
    <tr style='page-break-inside:avoid;height:.25in'>
        <td width="86" valign=top style=' height:.25in'>
            <p style='margin-left:0in;text-indent:0pt;text-align:center;margin-top:2.0pt;margin-bottom:2.0pt'><font size=2>23.1</font></p> </td>
        <td width="19" valign=top style=' height:.25in'>
            <p style='margin-left:0in;text-indent:0pt;text-align:left;margin-top:2.0pt;margin-bottom: 2.0pt'><font size=1>&nbsp;</font></p> </td>
        <td width="518" valign=top style=' height:.25in'>
            <p style='margin-left:0in;text-indent:0pt;text-align:left;margin-top:2.0pt;margin-bottom: 2.0pt'><font size=2>Consent of Tanner&nbsp;LC, Independent Registered Public Accounting Firm.</font></p> </td> </tr>
    <tr style='page-break-inside:avoid;height:.25in'>
        <td width="86" valign=top style=' height:.25in'>
            <p style='margin-left:0in;text-indent:0pt;text-align:center;margin-top:2.0pt;margin-bottom:2.0pt'><font size=2>23.2</font></p> </td>
        <td width="19" valign=top style=' height:.25in'>
            <p style='margin-left:0in;text-indent:0pt;text-align:left;margin-top:2.0pt;margin-bottom: 2.0pt'><font size=1>&nbsp;</font></p> </td>
        <td width="518" valign=top style=' height:.25in'>
            <p style='margin-left:0in;text-indent:0pt;text-align:left;margin-top:2.0pt;margin-bottom: 2.0pt'><font size=2>Consent of Dorsey&nbsp;&amp; Whitney&nbsp;LLP (contained in Exhibit&nbsp;5.1 to this Registration Statement).</font></p> </td> </tr>
    <tr style='page-break-inside:avoid; height:40.2pt'>
        <td width="86" valign=top style=' height:40.2pt'>
            <p style='margin-left:0in;text-indent:0pt;text-align:center;margin-top:2.0pt;margin-bottom:2.0pt'><font size=2>24.1</font></p> </td>
        <td width="19" valign=top style=' height:40.2pt'>
            <p style='margin-left:0in;text-indent:0pt;text-align:left;margin-top:2.0pt;margin-bottom: 2.0pt'><font size=1>&nbsp;</font></p> </td>
        <td width="518" valign=top style=' height:40.2pt'>
            <p style='margin-left:0in;text-indent:0pt;text-align:left;margin-top:2.0pt;margin-bottom: 2.0pt'><font size=2>Power of Attorney (included with the signatures in Part&nbsp;II of this registration statement).</font></p> </td> </tr></table>

<p style=' margin-bottom:0pt; margin-top:0pt;text-align:left;'><font size=2>&nbsp;</font></p>

<table border="0" cellspacing=0 cellpadding=0 width="100%" style='border-collapse:collapse'>
    <tr >
        <td width="7%" nowrap valign=top style='padding:0in 0in 12.0pt 0in; '>
            <p style='margin-left:0pt;text-indent:0pt;text-align:left;margin-top:0pt;margin-bottom:0pt'><b><font size=2>Item 9.</font></b></p> </td>
        <td nowrap valign=top style='padding:0in 0in 12.0pt 0in; '>
            <p style='margin-left:0pt;text-indent:0pt;text-align:left;margin-top:0pt;margin-bottom:0pt'><b><font size=2>Undertakings.</font></b></p> </td> </tr></table>



<!-- MARKER FORMAT-SHEET="Para Indent Level 1" FSL="Default" -->
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0>
<TR VALIGN=TOP>
<TD WIDTH=5%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>&nbsp; </FONT></TD>
<TD WIDTH=95%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
undersigned registrant hereby undertakes: </FONT>
</TD>
</TR>
</TABLE>
<BR>

<!-- MARKER FORMAT-SHEET="Para Indent Level 2" FSL="Default" -->
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0>
<TR VALIGN=TOP>
<TD WIDTH=10%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>&nbsp; </FONT></TD>
<TD WIDTH=90%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;To
file, during any period in which offers or sales are being made, a post-effective
amendment to this Registration Statement: </FONT>
</TD>
</TR>
</TABLE>
<BR>


<!-- MARKER FORMAT-SHEET="Para Indent Level 3" FSL="Default" -->
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0>
<TR VALIGN=TOP>
<TD WIDTH=15%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>&nbsp; </FONT></TD>
<TD WIDTH=85%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;To
include any prospectus required by Section&nbsp;10(a)(3) of the Securities Act of&nbsp;1933,
as amended (the &#147;Securities Act&#148;);  </FONT>
</TD>
</TR>
</TABLE>
<BR>

<!-- MARKER FORMAT-SHEET="Para Indent Level 3" FSL="Default" -->
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0>
<TR VALIGN=TOP>
<TD WIDTH=15%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>&nbsp; </FONT></TD>
<TD WIDTH=85%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;To
reflect in the prospectus any facts or events arising after the effective date of the
Registration Statement (or the most recent post-effective amendment thereof) which,
individually or in the aggregate, represent a  </FONT>
</TD>
</TR>
</TABLE>
<BR>

<p style=' margin-bottom:0pt; margin-top:0pt; margin-left:15.38%;text-align:left;'><font size=2>&nbsp;</font></p>
<BR>
<!-- MARKER FORMAT-SHEET="Para Default" FSL="Default" -->
<P align=center><FONT FACE="Times New Roman, Times, Serif" SIZE=2>II-3 </FONT></P>
<BR>


<HR SIZE=2 COLOR=black NOSHADE>

<p style='page-break-before:always'></p>

<p style=' margin-bottom:0pt; margin-top:0pt;text-align:left;'><font size=2>&nbsp;</font></p>

<p style=' margin-bottom:12pt; margin-top:0pt; margin-left:15.38%;text-align:left;'><font size=2>fundamental change in the information set forth in the Registration Statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule&nbsp;424(b) if, in the aggregate, the changes in volume and price represent no more than a&nbsp;20% change in the maximum aggregate offering price set forth in the &#147;Calculation of Registration Fee&#148; table in the effective Registration Statement; and</font></p>

<!-- MARKER FORMAT-SHEET="Para Indent Level 3" FSL="Default" -->
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0>
<TR VALIGN=TOP>
<TD WIDTH=15%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>&nbsp; </FONT></TD>
<TD WIDTH=85%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;To
include any material information with respect to the plan of distribution not previously
disclosed in the Registration Statement or any material change to such information in the
Registration Statement; </FONT>
</TD>
</TR>
</TABLE>
<BR>

<p style=' margin-bottom:12pt; margin-top:0pt; margin-left:7.69%;text-align:left;'><font size=2>Provided, however, that paragraphs&nbsp;(a)(1)(i) and&nbsp;(a)(1)(ii) above do not apply if the information required to be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the Commission by the registrant pursuant to Section&nbsp;13 or Section&nbsp;15(d) of the Exchange Act that are incorporated by reference in the Registration Statement.</font></p>

<!-- MARKER FORMAT-SHEET="Para Indent Level 2" FSL="Default" -->
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0>
<TR VALIGN=TOP>
<TD WIDTH=10%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>&nbsp; </FONT></TD>
<TD WIDTH=90%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;That,
for the purpose of determining any liability under the Securities Act, each such
post-effective amendment shall be deemed to be a new Registration Statement relating to
the securities offered therein, and the offering of such securities at that time shall be
deemed to be the initial bona fide offering thereof. </FONT>
</TD>
</TR>
</TABLE>
<BR>

<!-- MARKER FORMAT-SHEET="Para Indent Level 2" FSL="Default" -->
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0>
<TR VALIGN=TOP>
<TD WIDTH=10%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>&nbsp; </FONT></TD>
<TD WIDTH=90%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;To
remove from registration by means of a post-effective amendment any of the securities
being registered which remain unsold at the termination of the offering. </FONT>
</TD>
</TR>
</TABLE>
<BR>

<p style=' margin-bottom:12pt; margin-top:0pt; text-indent:7.0%;text-align:left;'><font size=2>(b)</font><font size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font><font size=2>The undersigned registrant hereby undertakes that, for purposes of determining any liability under the Securities Act, each filing of the registrant&#146;s annual report pursuant to Section&nbsp;13(a) or Section&nbsp;15(d) of the Exchange Act that is incorporated by reference in the Registration Statement shall be deemed to be a new Registration Statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.</font></p>

<p style=' margin-bottom:12pt; margin-top:0pt; text-indent:7.0%;text-align:left;'><font size=2>(c)</font><font size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font><font size=2>Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the Commission such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless
in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.</font></p>

<p style=' margin-bottom:0pt; margin-top:0pt;text-align:left;'><font size=2>&nbsp;</font></p>

<p style=' margin-bottom:0pt; margin-top:0pt;text-align:left;'><font size=2>&nbsp;</font></p>

<!-- MARKER FORMAT-SHEET="Para Default" FSL="Default" -->
<P align=center><FONT FACE="Times New Roman, Times, Serif" SIZE=2>II-4 </FONT></P>
<BR>


<HR SIZE=2 COLOR=black NOSHADE>

<p style='page-break-before:always'></p>

<p style=' margin-bottom:0pt; margin-top:0pt;text-align:left;'><font size=2>&nbsp;</font></p>

<p style=' margin-bottom:0pt; margin-top:0pt;text-align:left;'><font size=2>&nbsp;</font></p>

<p align=center style=' margin-bottom:12pt; margin-top:0pt;'>
<FONT SIZE="2"><B>SIGNATURES</B> </FONT></p>
<BR>



<p style=' margin-bottom:12pt; margin-top:0pt; text-indent:7.0%;text-align:left;'><font size=2>Pursuant to the requirements of the Securities Act of&nbsp;1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form&nbsp;S-8 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Salt Lake City, State of Utah, on January 29, 2009.</font></p>

<p style=' margin-bottom:0pt; margin-top:0pt; margin-left:50.15%;text-align:left;'><B><font SIZE=2>BSD MEDICAL CORPORATION</font></B></p>

<p style=' margin-bottom:0pt; margin-top:0pt; margin-left:50.15%;text-align:left;'><font size=2>&nbsp;</font></p>

<p style=' margin-bottom:0pt; margin-top:0pt; margin-left:50.15%;text-align:left;'><font size=2>By   &nbsp;&nbsp;</font><u><font size=2>/s/ Hyrum A. Mead&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></u></p>

<p style=' margin-bottom:0pt; margin-top:0pt; margin-left:52.0%;text-align:left;'><font size=2>Name:  Hyrum A. Mead</font></p>

<p style=' margin-bottom:12pt; margin-top:0pt; margin-left:52.0%;text-align:left;'><font size=2>Title:  President and Chief Executive Officer</font></p>

<p style=' margin-bottom:0pt; margin-top:0pt;text-align:center;'><font size=2>&nbsp;</font></p>

<p style=' margin-bottom:12pt; margin-top:0pt;text-align:center;'><B><font SIZE=2>POWER OF ATTORNEY </font></B></p>

<p style=' margin-bottom:12pt; margin-top:0pt; text-indent:7.0%;text-align:left;'><font size=2>Each person whose signature appears below constitutes and appoints Hyrum A. Mead and Paul&nbsp;F. Turner, his or her true and lawful attorney-in-fact and agent with full powers of substitution and resubstitution, for him or her and in his or her name, place and stead, in any and all capacities, to sign any and all amendments (including post-effective amendments) to this registration statement and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorney-in-fact and agent full power and authority to do and perform each and every act and thing requisite and necessary to be done in about the premises, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorney-in-fact and agent or his or her substitute or substitutes,
may lawfully do or cause to be done by virtue hereof.</font></p>

<p style=' margin-bottom:12pt; margin-top:0pt; text-indent:7.0%;text-align:left;'><font size=2>Pursuant to the requirements of the Securities Act of&nbsp;1933, this registration statement has been signed by the following persons in the capacities indicated on</font><b><font size=2> </font></b><font size=2>January 29, 2009.</font></p>

<p style=' margin-bottom:0pt; margin-top:0pt; text-indent:7.0%;text-align:left;'><font size=2>&nbsp;</font></p>


<table width="100%" border="0" cellspacing=0 cellpadding=0 style='border-collapse:collapse'>
    <tr style='page-break-inside:avoid;height:.65in'>
        <td width="334" valign=top style='padding:0in 5.4pt 0in 5.4pt; height:.65in'>
            <p style='margin-left:0pt;text-indent:0pt;text-align:left;margin-top:0pt;margin-bottom:0pt'><u><font size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;/s/ Paul F. Turner&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></u></p>
<p style='margin-left:0pt;text-indent:85.5pt;text-align:left;margin-top:0pt;margin-bottom:0pt'><font size=2>Paul F. Turner</font></p> </td>
        <td width="28" valign=top style='padding:0in 5.4pt 0in 5.4pt; height:.65in'>
            <p style='margin-left:0pt;text-indent:0pt;text-align:left;margin-top:0pt;margin-bottom:0pt'><font size=1>&nbsp;</font></p> </td>
        <td width="276" valign=top style='padding:0in 5.4pt 0in 5.4pt; height:.65in'>
            <p style='margin-left:0pt;text-indent:0pt;text-align:left;margin-top:0pt;margin-bottom:0pt'><font size=2>Chairman of the Board, Senior Vice President and Chief Technology Officer</font></p> </td> </tr>
    <tr style='page-break-inside:avoid;height:54.5pt'>
        <td width="334" valign=top style='padding:0in 5.4pt 0in 5.4pt; height:54.5pt'>
            <p style='margin-left:0pt;text-indent:0pt;text-align:left;margin-top:0pt;margin-bottom:0pt'><u><font size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;/s/ Hyrum A. Mead&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></u></p>
<p style='margin-left:0pt;text-indent:81.0pt;text-align:left;margin-top:0pt;margin-bottom:0pt'><font size=2>Hyrum A. Mead</font></p> </td>
        <td width="28" valign=top style='padding:0in 5.4pt 0in 5.4pt; height:54.5pt'>
            <p style='margin-left:0pt;text-indent:0pt;text-align:left;margin-top:0pt;margin-bottom:0pt'><font size=1>&nbsp;</font></p> </td>
        <td width="276" valign=top style='padding:0in 5.4pt 0in 5.4pt; height:54.5pt'>
            <p style='margin-left:0pt;text-indent:0pt;text-align:left;margin-top:0pt;margin-bottom:0pt'><font size=2>President and Chief Executive Officer (principal executive officer) and Director</font>  </p> </td> </tr>
    <tr style='page-break-inside:avoid; height:.65in'>
        <td width="334" valign=top style='padding:0in 5.4pt 0in 5.4pt; height:.65in'>
            <p style='margin-left:0pt;text-indent:0pt;text-align:left;margin-top:0pt;margin-bottom:0pt'><u><font size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;/s/ Dennis P. Gauger&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></u></p>
<p style='margin-left:0pt;text-indent:78.0pt;text-align:left;margin-top:0pt;margin-bottom:0pt'><font size=2>Dennis P. Gauger</font></p> </td>
        <td width="28" valign=top style='padding:0in 5.4pt 0in 5.4pt; height:.65in'>
            <p style='margin-left:0pt;text-indent:0pt;text-align:left;margin-top:0pt;margin-bottom:0pt'><font size=1>&nbsp;</font></p> </td>
        <td width="276" valign=top style='padding:0in 5.4pt 0in 5.4pt; height:.65in'>
            <p style='margin-left:0pt;text-indent:0pt;text-align:left;margin-top:0pt;margin-bottom:0pt'><font size=2>Chief Financial Officer (principal financial and accounting officer)</font></p> </td> </tr></table>

<p style=' margin-bottom:0pt; margin-top:0pt;text-align:left;'><font size=2>&nbsp;</font></p>




<table width="100%" border="0" cellspacing=0 cellpadding=0 style='border-collapse:collapse'>
    <tr style='page-break-inside:avoid;height:.65in'>
        <td width="334" valign=top style='padding:0in 5.4pt 0in 5.4pt; height:.65in'>
            <p style='margin-left:0pt;text-indent:0pt;text-align:left;margin-top:0pt;margin-bottom:0pt'><u><font size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;/s/ Gerhard W. Sennewald&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></u></p>
<p style='margin-left:0pt;text-indent:63.75pt;text-align:left;margin-top:0pt;margin-bottom:0pt'><font size=2>Gerhard W. Sennewald</font></p> </td>
        <td width="28" valign=top style='padding:0in 5.4pt 0in 5.4pt; height:.65in'>
            <p style='margin-left:0pt;text-indent:0pt;text-align:left;margin-top:0pt;margin-bottom:0pt'><font size=1>&nbsp;</font></p> </td>
        <td width="276" valign=top style='padding:0in 5.4pt 0in 5.4pt; height:.65in'>
            <p style='margin-left:0pt;text-indent:0pt;text-align:left;margin-top:0pt;margin-bottom:0pt'><font size=2>Director</font></p> </td> </tr>
    <tr style='page-break-inside:avoid;height:.65in'>
        <td width="334" valign=top style='padding:0in 5.4pt 0in 5.4pt; height:.65in'>
            <p style='margin-left:0pt;text-indent:0pt;text-align:left;margin-top:0pt;margin-bottom:0pt'><u><font size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;/s/ Michael Nobel&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></u></p>
<p style='margin-left:0pt;text-indent:84.0pt;text-align:left;margin-top:0pt;margin-bottom:0pt'><font size=2>Michael Nobel</font></p> </td>
        <td width="28" valign=top style='padding:0in 5.4pt 0in 5.4pt; height:.65in'>
            <p style='margin-left:0pt;text-indent:0pt;text-align:left;margin-top:0pt;margin-bottom:0pt'><font size=1>&nbsp;</font></p> </td>
        <td width="276" valign=top style='padding:0in 5.4pt 0in 5.4pt; height:.65in'>
            <p style='margin-left:0pt;text-indent:0pt;text-align:left;margin-top:0pt;margin-bottom:0pt'><font size=2>Director</font></p> </td> </tr>
    <tr style='page-break-inside:avoid;height:.65in'>
        <td width="334" valign=top style='padding:0in 5.4pt 0in 5.4pt; height:.65in'>
            <p style='margin-left:0pt;text-indent:0pt;text-align:left;margin-top:0pt;margin-bottom:0pt'><u><font size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;/s/ Douglas P. Boyd&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></u></p>
<p style='margin-left:0pt;text-indent:79.5pt;text-align:left;margin-top:0pt;margin-bottom:0pt'><font size=2>Douglas P. Boyd</font></p> </td>
        <td width="28" valign=top style='padding:0in 5.4pt 0in 5.4pt; height:.65in'>
            <p style='margin-left:0pt;text-indent:0pt;text-align:left;margin-top:0pt;margin-bottom:0pt'><font size=1>&nbsp;</font></p> </td>
        <td width="276" valign=top style='padding:0in 5.4pt 0in 5.4pt; height:.65in'>
            <p style='margin-left:0pt;text-indent:0pt;text-align:left;margin-top:0pt;margin-bottom:0pt'><font size=2>Director</font></p> </td> </tr>
    <tr style='page-break-inside:avoid;height:.65in'>
        <td width="334" valign=top style='padding:0in 5.4pt 0in 5.4pt; height:.65in'>
            <p style='margin-left:0pt;text-indent:0pt;text-align:left;margin-top:0pt;margin-bottom:0pt'><u><font size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;/s/ Steven G. Stewart&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></u></p>
<p style='margin-left:0pt;text-indent:76.5pt;text-align:left;margin-top:0pt;margin-bottom:0pt'><font size=2>Steven G. Stewart</font></p> </td>
        <td width="28" valign=top style='padding:0in 5.4pt 0in 5.4pt; height:.65in'>
            <p style='margin-left:0pt;text-indent:0pt;text-align:left;margin-top:0pt;margin-bottom:0pt'><font size=1>&nbsp;</font></p> </td>
        <td width="276" valign=top style='padding:0in 5.4pt 0in 5.4pt; height:.65in'>
            <p style='margin-left:0pt;text-indent:0pt;text-align:left;margin-top:0pt;margin-bottom:0pt'><font size=2>Director</font></p> </td> </tr>
    <tr style='page-break-inside:avoid; height:.65in'>
        <td width="334" valign=top style='padding:0in 5.4pt 0in 5.4pt; height:.65in'>
            <p style='margin-left:0pt;text-indent:0pt;text-align:left;margin-top:0pt;margin-bottom:0pt'><u><font size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;/s/ Timothy C. McQuay&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></u></p>
<p style='margin-left:0pt;text-indent:69.75pt;text-align:left;margin-top:0pt;margin-bottom:0pt'><font size=2>Timothy C. McQuay</font></p> </td>
        <td width="28" valign=top style='padding:0in 5.4pt 0in 5.4pt; height:.65in'>
            <p style='margin-left:0pt;text-indent:0pt;text-align:left;margin-top:0pt;margin-bottom:0pt'><font size=1>&nbsp;</font></p> </td>
        <td width="276" valign=top style='padding:0in 5.4pt 0in 5.4pt; height:.65in'>
            <p style='margin-left:0pt;text-indent:0pt;text-align:left;margin-top:0pt;margin-bottom:0pt'><font size=2>Director</font></p> </td> </tr></table>

<p style=' margin-bottom:0pt; margin-top:0pt;text-align:left;'><font size=2>&nbsp;</font></p>

<p style=' margin-bottom:0pt; margin-top:0pt;text-align:left;'><font size=2>&nbsp;</font></p>

<p style=' margin-bottom:0pt; margin-top:0pt;text-align:left;'><font size=2>&nbsp;</font></p>

<p style=' margin-bottom:0pt; margin-top:0pt;text-align:left;'><font size=2>&nbsp;</font></p>


<p style=' margin-bottom:0pt; margin-top:0pt;text-align:left;'><font size=2>&nbsp;</font></p>

<p style=' margin-bottom:0pt; margin-top:0pt;text-align:left;'><font size=2>&nbsp;</font></p>


<!-- MARKER FORMAT-SHEET="Para Default" FSL="Default" -->
<P align=center><FONT FACE="Times New Roman, Times, Serif" SIZE=2>II-5 </FONT></P>
<BR>


<HR SIZE=2 COLOR=black NOSHADE>

<BR><BR>

<!-- MARKER FORMAT-SHEET="Para Default" FSL="Default" -->
<P align=center>
<FONT FACE="Times New Roman, Times, Serif" SIZE="2"><B>Exhibit Index to<BR>
Form S-8<BR>
<BR>
BSD Medical Corporation</B> </FONT> </P>
<BR>



<table width="100%" border="0" cellspacing=0 cellpadding=0 style='border-collapse:collapse'>
    <tr style='page-break-inside:avoid;height:.5in'>
        <td width="86" valign=bottom style='border-bottom: solid black 1.0pt; height:.5in'>
            <p style='margin-left:0pt;text-indent:0pt;text-align:center;margin-top:0pt;margin-bottom:0pt'><b><font size=2>Exhibit</font></b><br> <b><font size=2>Number</font></b></p> </td>
        <td width="19" valign=bottom style=' height:.5in'>
            <p style='margin-left:0pt;text-indent:0pt;text-align:center;margin-top:1.0pt;margin-bottom:0pt'><font size=1>&nbsp;</font></p> </td>
        <td width="518" valign=bottom style='border-bottom: solid black 1.0pt; height:.5in'>
            <p style='margin-left:0pt;text-indent:0pt;text-align:center;margin-top:0pt;margin-bottom:0pt'><b><font size=2>Description</font></b></p> </td> </tr>
    <tr style='page-break-inside:avoid;height:.25in'>
        <td width="86" valign=top style='height:.25in'>
            <p style='margin-left:0in;text-indent:0pt;text-align:center;margin-top:2.0pt;margin-bottom:2.0pt'><font size=2>4.1</font></p> </td>
        <td width="19" valign=top style=' height:.25in'>
            <p style='margin-left:0in;text-indent:0pt;text-align:left;margin-top:2.0pt;margin-bottom: 2.0pt'><font size=1>&nbsp;</font></p> </td>
        <td width="518" valign=top style='height:.25in'>
            <p style='margin-left:0in;text-indent:0pt;text-align:left;margin-top:2.0pt;margin-bottom: 2.0pt'><font size=2>Amended and Restated Certificate of Incorporation. Incorporated by reference to Exhibit&nbsp;3.1 of the&nbsp;BSD Medical Corporation Form&nbsp;10-KSB filed December&nbsp;1,&nbsp;2003 (File Number&nbsp;000-10783).</font></p> </td> </tr>
    <tr style='page-break-inside:avoid;height:.25in'>
        <td width="86" valign=top style=' height:.25in'>
            <p style='margin-left:0in;text-indent:0pt;text-align:center;margin-top:2.0pt;margin-bottom:2.0pt'><font size=2>4.2</font></p> </td>
        <td width="19" valign=top style=' height:.25in'>
            <p style='margin-left:0in;text-indent:0pt;text-align:left;margin-top:2.0pt;margin-bottom: 2.0pt'><font size=1>&nbsp;</font></p> </td>
        <td width="518" valign=top style=' height:.25in'>
            <p style='margin-left:0in;text-indent:0pt;text-align:left;margin-top:2.0pt;margin-bottom: 2.0pt'><font size=2>Bylaws. Incorporated by reference to Exhibit&nbsp;3.2 of the&nbsp;BSD Medical Corporation Registration Statement on Form S-1, filed October&nbsp;16,&nbsp;1986 (File Number&nbsp;033-09534).</font></p> </td> </tr>
    <tr style='page-break-inside:avoid;height:.25in'>
        <td width="86" valign=top style=' height:.25in'>
            <p style='margin-left:0in;text-indent:0pt;text-align:center;margin-top:2.0pt;margin-bottom:2.0pt'><font size=2>4.3</font></p> </td>
        <td width="19" valign=top style=' height:.25in'>
            <p style='margin-left:0in;text-indent:0pt;text-align:left;margin-top:2.0pt;margin-bottom: 2.0pt'><font size=1>&nbsp;</font></p> </td>
        <td width="518" valign=top style=' height:.25in'>
            <p style='margin-left:0in;text-indent:0pt;text-align:left;margin-top:2.0pt;margin-bottom: 2.0pt'><font size=2>Amendment to Bylaws. Incorporated by reference to Exhibit 3.1 of the BSD Medical Corporation Current Report on Form 8-K, filed January 4, 2008 (File Number&nbsp;001-32526).</font></p> </td> </tr>
    <tr style='page-break-inside:avoid;height:.25in'>
        <td width="86" valign=top style=' height:.25in'>
            <p style='margin-left:0in;text-indent:0pt;text-align:center;margin-top:2.0pt;margin-bottom:2.0pt'><font size=2>4.4</font></p> </td>
        <td width="19" valign=top style=' height:.25in'>
            <p style='margin-left:0in;text-indent:0pt;text-align:left;margin-top:2.0pt;margin-bottom: 2.0pt'><font size=1>&nbsp;</font></p> </td>
        <td width="518" valign=top style=' height:.25in'>
            <p style='margin-left:0in;text-indent:0pt;text-align:left;margin-top:2.0pt;margin-bottom: 2.0pt'><font size=2>Specimen Common Stock Certificate. Incorporated by reference to Exhibit&nbsp;4 of the&nbsp;BSD Medical Corporation Registration Statement on Form&nbsp;S-1, filed October&nbsp;16,&nbsp;1986 (File Number&nbsp;033-09534).</font></p> </td> </tr>
    <tr style='page-break-inside:avoid;height:.25in'>
        <td width="86" valign=top style=' height:.25in'>
            <p style='margin-left:0in;text-indent:0pt;text-align:center;margin-top:2.0pt;margin-bottom:2.0pt'><font size=2>5.1</font></p> </td>
        <td width="19" valign=top style=' height:.25in'>
            <p style='margin-left:0in;text-indent:0pt;text-align:left;margin-top:2.0pt;margin-bottom: 2.0pt'><font size=1>&nbsp;</font></p> </td>
        <td width="518" valign=top style=' height:.25in'>
            <p style='margin-left:0in;text-indent:0pt;text-align:left;margin-top:2.0pt;margin-bottom: 2.0pt'><font size=2>Opinion of Dorsey&nbsp;&amp; Whitney LLP.</font></p> </td> </tr>
    <tr style='page-break-inside:avoid;height:.25in'>
        <td width="86" valign=top style=' height:.25in'>
            <p style='margin-left:0in;text-indent:0pt;text-align:center;margin-top:2.0pt;margin-bottom:2.0pt'><font size=2>10.1</font></p> </td>
        <td width="19" valign=top style=' height:.25in'>
            <p style='margin-left:0in;text-indent:0pt;text-align:left;margin-top:2.0pt;margin-bottom: 2.0pt'><font size=1>&nbsp;</font></p> </td>
        <td width="518" valign=top style=' height:.25in'>
            <p style='margin-left:0in;text-indent:0pt;text-align:left;margin-top:2.0pt;margin-bottom: 2.0pt'><font size=2>BSD Medical Corporation Second Amended and Restated 1998 Stock Incentive Plan. Incorporated by reference to Appendix&nbsp;B of the BSD Medical Corporation Proxy Statement, filed January&nbsp;3,&nbsp;2008 (File No.&nbsp;001-32526).</font></p> </td> </tr>
    <tr style='page-break-inside:avoid;height:.25in'>
        <td width="86" valign=top style=' height:.25in'>
            <p style='margin-left:0in;text-indent:0pt;text-align:center;margin-top:2.0pt;margin-bottom:2.0pt'><font size=2>10.2</font></p> </td>
        <td width="19" valign=top style=' height:.25in'>
            <p style='margin-left:0in;text-indent:0pt;text-align:left;margin-top:2.0pt;margin-bottom: 2.0pt'><font size=1>&nbsp;</font></p> </td>
        <td width="518" valign=top style=' height:.25in'>
            <p style='margin-left:0in;text-indent:0pt;text-align:left;margin-top:2.0pt;margin-bottom: 2.0pt'><font size=2>BSD Medical Corporation Second Amended and Restated 1998 Director Stock Plan. Incorporated by reference to Appendix&nbsp;A of the BSD Medical Corporation Proxy Statement, filed January&nbsp;3,&nbsp;2008 (File No.&nbsp;001-32526). </font></p> </td> </tr>
    <tr style='page-break-inside:avoid;height:.25in'>
        <td width="86" valign=top style=' height:.25in'>
            <p style='margin-left:0in;text-indent:0pt;text-align:center;margin-top:2.0pt;margin-bottom:2.0pt'><font size=2>23.1</font></p> </td>
        <td width="19" valign=top style=' height:.25in'>
            <p style='margin-left:0in;text-indent:0pt;text-align:left;margin-top:2.0pt;margin-bottom: 2.0pt'><font size=1>&nbsp;</font></p> </td>
        <td width="518" valign=top style=' height:.25in'>
            <p style='margin-left:0in;text-indent:0pt;text-align:left;margin-top:2.0pt;margin-bottom: 2.0pt'><font size=2>Consent of Tanner&nbsp;LC, Independent Registered Public Accounting Firm.</font></p> </td> </tr>
    <tr style='page-break-inside:avoid;height:.25in'>
        <td width="86" valign=top style=' height:.25in'>
            <p style='margin-left:0in;text-indent:0pt;text-align:center;margin-top:2.0pt;margin-bottom:2.0pt'><font size=2>23.2</font></p> </td>
        <td width="19" valign=top style=' height:.25in'>
            <p style='margin-left:0in;text-indent:0pt;text-align:left;margin-top:2.0pt;margin-bottom: 2.0pt'><font size=1>&nbsp;</font></p> </td>
        <td width="518" valign=top style=' height:.25in'>
            <p style='margin-left:0in;text-indent:0pt;text-align:left;margin-top:2.0pt;margin-bottom: 2.0pt'><font size=2>Consent of Dorsey&nbsp;&amp; Whitney&nbsp;LLP (contained in Exhibit&nbsp;5.1 to this Registration Statement).</font></p> </td> </tr>
    <tr style='page-break-inside:avoid; height:40.2pt'>
        <td width="86" valign=top style=' height:40.2pt'>
            <p style='margin-left:0in;text-indent:0pt;text-align:center;margin-top:2.0pt;margin-bottom:2.0pt'><font size=2>24.1</font></p> </td>
        <td width="19" valign=top style=' height:40.2pt'>
            <p style='margin-left:0in;text-indent:0pt;text-align:left;margin-top:2.0pt;margin-bottom: 2.0pt'><font size=1>&nbsp;</font></p> </td>
        <td width="518" valign=top style=' height:40.2pt'>
            <p style='margin-left:0in;text-indent:0pt;text-align:left;margin-top:2.0pt;margin-bottom: 2.0pt'><font size=2>Power of Attorney (included with the signatures in Part&nbsp;II of this registration statement).</font></p> </td> </tr></table>

<p style=' margin-bottom:0pt; margin-top:0pt;text-align:left;'><font size=2>&nbsp;</font></p>



<!-- MARKER FORMAT-SHEET="Para Default" FSL="Default" -->
<P align=center><FONT FACE="Times New Roman, Times, Serif" SIZE=2>II-6 </FONT></P>
<BR>



<HR SIZE=2 COLOR=black NOSHADE>




</BODY>
</HTML>
[{"type": "S-8", "sequence": "1", "filename": "bsd_forms8-01292009.htm", "secsgml_size_bytes": 80153}]
{"company-data": {"conformed-name": "BSD MEDICAL CORP", "cik": "0000320174", "assigned-sic": "3845", "irs-number": "751590407", "state-of-incorporation": "DE", "fiscal-year-end": "0831"}, "filing-values": {"form-type": "S-8", "act": "33", "file-number": "333-157025", "film-number": "09556079"}, "business-address": {"street1": "2188 W 2200 SOUTH", "city": "SALT LAKE CITY", "state": "UT", "zip": "84119", "phone": "8019725555"}, "mail-address": {"street1": "2188 WEST", "street2": "2200 SOUTH", "city": "SALT LAKE CITY", "state": "UT", "zip": "84119"}}
Registration No. 333-__________
As filed with the Securities and Exchange Commission on January 29, 2009
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
____________________
FORM
S-8
REGISTRATION STATEMENT
Under
THE SECURITIES ACT OF 1933
____________________
BSD MEDICAL CORPORATION
(Exact name of registrant as specified in its charter)
Delaware
(State   or   other   jurisdiction
of
incorporation or organization)
75-1590407
(I.R.S. Employer
Identification No.)
2188 West 2200 South
Salt Lake City, Utah  84119
(Address, including zip code,
of registrant's principal executive offices)
____________________
Amended and Restated 1998 Stock Incentive Plan
Amended and Restated 1998 Director Stock Plan
(Full title of the plan)
____________________
Hyrum A. Mead
President
BSD Medical Corporation
2188 West 2200
South
Salt Lake City, Utah  84119
(801) 972-5555
(Name, address and telephone number,
including area code, of agent for service of process)
____________________
Copy to:
Nolan S. Taylor
Dorsey & Whitney LLP
136 South Main Street, Suite 1000
Salt Lake City, Utah  84101
(801) 933-7360
____________________
Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See the definitions of "large accelerated filer," "accelerated filer" and "smaller reporting company" in Rule 12b-2 of the Exchange Act. (Check one):
Large accelerated filer
o
Accelerated filer
x
Non-accelerated filer
o
Smaller reporting company
x
CALCULATION OF REGISTRATION FEE
Title of securities to be registered
Amount to
be registered(1)
Proposed maximum
offering price per share
Proposed maximum
aggregate offering price
Amount of registration fee
Common Stock, $0.001
par value per share, issuable pursuant to the Amended and Restated 1998 Stock Incentive Plan
750,000
$3.54(2)
$2,655,500(2)
$104.36
Common Stock, $0.001
par value per share, issuable pursuant to the Amended and Restated 1998 Director Stock Plan
885,278
$4.36(3)
$3,860,055(3)
$151.70
Total
1,635,278
$6,515,555
$256.06
(1)
This Registration Statement shall also cover any additional shares of the Registrant's common stock that become issuable by reason of any stock dividend, stock split, recapitalization or any other similar transaction effected without the Registrant's receipt of consideration which results in an increase in the number of outstanding shares of the Registrant's common stock.
(2)
Estimated solely for the purpose of calculating the registration fee in accordance with Rule 457(h)(1) and Rule 457(c) of the Securities Act of 1933, as amended. The proposed maximum aggregate offering price has been calculated as follows: options to purchase 175,000 shares of Common Stock have been granted with an exercise price of $5.81; the proposed maximum aggregate offering price of the remaining 575,000 shares of Common Stock that are being registered herein is based upon the average of the high and low prices of the registrant's Common Stock as reported on the Nasdaq Stock Market's consolidated reporting system on January 23, 2009.
(3)
Estimated solely for the purpose of calculating the registration fee in accordance with Rule 457(h)(1) and Rule 457(c) of the Securities Act of 1933, as amended. The proposed maximum aggregate offering price has been calculated as follows: options to purchase 573,825 shares of Common Stock have been granted with an exercise price of $5.18; the proposed maximum aggregate offering price of the remaining 311,453 shares of Common Stock that are being registered herein is based upon the average of the high and low prices of the registrant's Common Stock as reported on the Nasdaq Stock Market's consolidated reporting system on January 23, 2009.
PART I
INFORMATION REQUIRED IN THE SECTION 10(A) PROSPECTUS
Item 1.
Plan Information.
Information required by Item 1 to be contained in the Section 10(a) prospectus is omitted from this Registration Statement in accordance with Rule 428 adopted under the Securities Act of 1933, as amended (the "Securities Act"), and the Note to Part I of Form S-8.
Item 2.
Registrant Information and Employee Plan Annual Information.
Information required by Item 2 to be contained in the Section 10(a) prospectus is omitted from this Registration Statement in accordance with Rule 428 adopted under the Securities Act and the Note to Part I of Form S-8.
PART II
INFORMATION REQUIRED IN THE REGISTRATION STATEMENT
Item 3.
Incorporation of Documents by Reference.
The following documents, which have been filed with the Securities and Exchange Commission (the "Commission") by BSD Medical Corporation (the "Company"), are incorporated by reference in this Registration Statement, as of their respective dates:
(a)
the Company's Annual Report on Form 10-K for the fiscal year ended August 31, 2008;
(b)
the Company's Quarterly Report on Form 10-Q for the quarter ended November 30, 2008;
(c)
the Company's Current Reports on Form 8-K filed on September 11, 2008 and Form 8-K/A filed on September 9, 2008; and
(d)
the description of the Company's Common Stock, par value $0.001 per share, as contained in Item 1 of the Registration Statement on Form 8-A filed on April 22, 2008, including any amendment or report filed for the purpose of updating such description filed for the purpose of updating such description.
All documents filed by the Company pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Securities Exchange Act of 1934, as amended, subsequent to the date hereof and prior to the filing of a post-effective amendment which indicates that all securities offered hereby have been sold or which deregisters all securities remaining unsold shall be deemed to be incorporated by reference herein and to be a part hereof from the respective dates of filing of such documents.
II-1
Item 4.
Description of Securities.
Not applicable.
Item 5.
Interests of Named Experts and Counsel.
Not applicable.
Item 6.
Indemnification of Directors and Officers.
Indemnification
Section 145 of the Delaware General Corporation Law grants the Company the power to indemnify its officers and directors, under certain circumstances and subject to certain conditions and limitations as stated therein, against all expenses and liabilities incurred by or imposed upon them as a result of suits brought against them as such officers and directors if they act in good faith and in a manner they reasonably believe to be in or not opposed to the best interests of the Company, and, with respect to any criminal action or proceeding, have no reasonable cause to believe their conduct was unlawful.
Section 145 of the Delaware General Corporation Law permits a corporation to include in its charter documents, and in agreements between the corporation and its directors and officers, provisions expanding the scope of indemnification beyond that specifically provided by the current law.
Article 8 of the Company's Amended and Restated Certificate of Incorporation provides for the indemnification of directors to the fullest extent permissible under Delaware law.
Section 8 of Article IX of the Company's Bylaws provides for the indemnification of officers, directors and third parties acting on behalf of the Company if such person acted in good faith and in a manner reasonably believed to be in, and not opposed to, the Company's best interest, and, with respect to any criminal action or proceeding, the indemnified party had no reason to believe his or her conduct was unlawful.
Liability Insurance
Section 145 of the Delaware General Corporation Law also permits a Delaware corporation to purchase and maintain insurance on behalf of its directors and officers. The Company's  bylaws permit the registrant to purchase such insurance on behalf of its directors and officers. The Company maintains a policy of liability insurance for its officers and directors.
Item 7.
Exemption from Registration Claimed.
Not applicable.
II-2
Item 8.
Exhibits.
Exhibit
Number
Description
4.1
Amended and Restated Certificate of Incorporation. Incorporated by reference to Exhibit 3.1 of the BSD Medical Corporation Form 10-KSB filed December 1, 2003 (File Number 000-10783).
4.2
Bylaws. Incorporated by reference to Exhibit 3.2 of the BSD Medical Corporation Registration Statement on Form S-1, filed October 16, 1986 (File Number 033-09534).
4.3
Amendment to Bylaws. Incorporated by reference to Exhibit 3.1 of the BSD Medical Corporation Current Report on Form 8-K, filed January 4, 2008 (File Number 001-32526).
4.4
Specimen Common Stock Certificate. Incorporated by reference to Exhibit 4 of the BSD Medical Corporation Registration Statement on Form S-1, filed October 16, 1986 (File Number 033-09534).
5.1
Opinion of Dorsey & Whitney LLP.
10.1
BSD Medical Corporation Second Amended and Restated 1998 Stock Incentive Plan. Incorporated by reference to Appendix B of the BSD Medical Corporation Proxy Statement, filed January 3, 2008 (File No. 001-32526).
10.2
BSD Medical Corporation Second Amended and Restated 1998 Director Stock Plan. Incorporated by reference to Appendix A of the BSD Medical Corporation Proxy Statement, filed January 3, 2008 (File No. 001-32526).
23.1
Consent of Tanner LC, Independent Registered Public Accounting Firm.
23.2
Consent of Dorsey & Whitney LLP (contained in Exhibit 5.1 to this Registration Statement).
24.1
Power of Attorney (included with the signatures in Part II of this registration statement).
Item 9.
Undertakings.
(a)
            The
undersigned registrant hereby undertakes:
(1)          To
file, during any period in which offers or sales are being made, a post-effective
amendment to this Registration Statement:
(i)           To
include any prospectus required by Section 10(a)(3) of the Securities Act of 1933,
as amended (the "Securities Act");
(ii)          To
reflect in the prospectus any facts or events arising after the effective date of the
Registration Statement (or the most recent post-effective amendment thereof) which,
individually or in the aggregate, represent a
II-3
fundamental change in the information set forth in the Registration Statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than a 20% change in the maximum aggregate offering price set forth in the "Calculation of Registration Fee" table in the effective Registration Statement; and
(iii)        To
include any material information with respect to the plan of distribution not previously
disclosed in the Registration Statement or any material change to such information in the
Registration Statement;
Provided, however, that paragraphs (a)(1)(i) and (a)(1)(ii) above do not apply if the information required to be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the Commission by the registrant pursuant to Section 13 or Section 15(d) of the Exchange Act that are incorporated by reference in the Registration Statement.
(2)          That,
for the purpose of determining any liability under the Securities Act, each such
post-effective amendment shall be deemed to be a new Registration Statement relating to
the securities offered therein, and the offering of such securities at that time shall be
deemed to be the initial bona fide offering thereof.
(3)          To
remove from registration by means of a post-effective amendment any of the securities
being registered which remain unsold at the termination of the offering.
(b)
The undersigned registrant hereby undertakes that, for purposes of determining any liability under the Securities Act, each filing of the registrant's annual report pursuant to Section 13(a) or Section 15(d) of the Exchange Act that is incorporated by reference in the Registration Statement shall be deemed to be a new Registration Statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.
(c)
Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the Commission such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless
in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.
II-4
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Salt Lake City, State of Utah, on January 29, 2009.
BSD MEDICAL CORPORATION
By
/s/ Hyrum A. Mead
Name:  Hyrum A. Mead
Title:  President and Chief Executive Officer
POWER OF ATTORNEY
Each person whose signature appears below constitutes and appoints Hyrum A. Mead and Paul F. Turner, his or her true and lawful attorney-in-fact and agent with full powers of substitution and resubstitution, for him or her and in his or her name, place and stead, in any and all capacities, to sign any and all amendments (including post-effective amendments) to this registration statement and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorney-in-fact and agent full power and authority to do and perform each and every act and thing requisite and necessary to be done in about the premises, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorney-in-fact and agent or his or her substitute or substitutes,
may lawfully do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities indicated on
January 29, 2009.
/s/ Paul F. Turner
Paul F. Turner
Chairman of the Board, Senior Vice President and Chief Technology Officer
/s/ Hyrum A. Mead
Hyrum A. Mead
President and Chief Executive Officer (principal executive officer) and Director
/s/ Dennis P. Gauger
Dennis P. Gauger
Chief Financial Officer (principal financial and accounting officer)
/s/ Gerhard W. Sennewald
Gerhard W. Sennewald
Director
/s/ Michael Nobel
Michael Nobel
Director
/s/ Douglas P. Boyd
Douglas P. Boyd
Director
/s/ Steven G. Stewart
Steven G. Stewart
Director
/s/ Timothy C. McQuay
Timothy C. McQuay
Director
II-5
Exhibit Index to
Form S-8
BSD Medical Corporation
Exhibit
Number
Description
4.1
Amended and Restated Certificate of Incorporation. Incorporated by reference to Exhibit 3.1 of the BSD Medical Corporation Form 10-KSB filed December 1, 2003 (File Number 000-10783).
4.2
Bylaws. Incorporated by reference to Exhibit 3.2 of the BSD Medical Corporation Registration Statement on Form S-1, filed October 16, 1986 (File Number 033-09534).
4.3
Amendment to Bylaws. Incorporated by reference to Exhibit 3.1 of the BSD Medical Corporation Current Report on Form 8-K, filed January 4, 2008 (File Number 001-32526).
4.4
Specimen Common Stock Certificate. Incorporated by reference to Exhibit 4 of the BSD Medical Corporation Registration Statement on Form S-1, filed October 16, 1986 (File Number 033-09534).
5.1
Opinion of Dorsey & Whitney LLP.
10.1
BSD Medical Corporation Second Amended and Restated 1998 Stock Incentive Plan. Incorporated by reference to Appendix B of the BSD Medical Corporation Proxy Statement, filed January 3, 2008 (File No. 001-32526).
10.2
BSD Medical Corporation Second Amended and Restated 1998 Director Stock Plan. Incorporated by reference to Appendix A of the BSD Medical Corporation Proxy Statement, filed January 3, 2008 (File No. 001-32526).
23.1
Consent of Tanner LC, Independent Registered Public Accounting Firm.
23.2
Consent of Dorsey & Whitney LLP (contained in Exhibit 5.1 to this Registration Statement).
24.1
Power of Attorney (included with the signatures in Part II of this registration statement).
II-6